Brief: Auris Medical Announces Formation Of New Subsidiary For Development Projects In Tinnitus And Hearing Loss
Dec 30 (Reuters) - Auris Medical Holding Ltd EARS.O :
* AURIS MEDICAL ANNOUNCES FORMATION OF NEW SUBSIDIARY FOR
DEVELOPMENT PROJECTS IN TINNITUS AND HEARING LOSS
* AURIS MEDICAL - FORMATION OF NEW UNIT, ZILENTIN LTD., TO
BUNDLE
DEVELOPMENT PROJECTS FOR TREATMENT OF TINNITUS & HEARING LOSS IN
A SEPARATE ENTITY
* AURIS MEDICAL - ZILENTIN LTD. IS DOMICILED IN ZUG,
SWITZERLAND
Source text for Eikon: ID:nGNX6H075Q
Further company coverage: EARS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Altamira Therapeutics
See all newsBrief: Altamira Therapeutics Reports Full Year 2024 Results
Brief: Altamira Therapeutics Announces Transition From Nasdaq To OTC Markets
Brief: Altamira Therapeutics Provides Update On Nasdaq Listing
Brief: Altamira Therapeutics Provides Business Update And First Half 2024 Financial Results
Brief: Altamira Therapeutics Announces Pricing Of Up To $12.0 Mln Public Offering